Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1980 • 4,703 citations

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

1966 • 4,504 citations

Pathologic observations in systemic sclerosis (scleroderma)

1969 • 1,071 citations

A Simple Method for the Determination of Glomerular Filtration Rate

1972 • 870 citations

Spirometric Studies in Normal Subjects I

1963 • 643 citations

Spirometric Studies in Normal Subjects

1963 • 459 citations

Lymphocytes in the skin of patients with progressive systemic sclerosis

1984 • 369 citations

Cellular infiltrates in scleroderma skin

1977 • 356 citations

Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.

1988 • 347 citations

High resolution computed tomography in early scleroderma lung disease.

1991 • 270 citations

Isolated diffusing capacity reduction in systemic sclerosis

1992 • 237 citations

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1990 • 236 citations

Localization of collagen mRNA in normal and scleroderma skin by in‐situ hybridization

1988 • 207 citations

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.

1993 • 200 citations

Effect of aging alone on mechanical properties of the normal adult human lung

1977 • 189 citations

Mortality in systemic sclerosis (scleroderma).

1992 • 169 citations

ORGAN MANIFESTATIONS IN 100 PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS: A COMPARISON BETWEEN THE CREST SYNDROME AND DIFFUSE SCLERODERMA

1989 • 153 citations

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1989 • 149 citations

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three‐year, parallel, randomized, double‐blind study

1989 • 117 citations

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis

1987 • 84 citations

An appraisal of chloroquine

1970 • 79 citations

Serial pulmonary function in systemic sclerosis

1982 • 79 citations

Clinical and Demographic Predictors of Loss of Pulmonary Function in Systemic Sclerosis

1984 • 76 citations

Treatment of systemic sclerosis.

1991 • 51 citations

SPONTANEOUS PRODUCTION OF FIBRONECTIN BY ALVEOLAR MACROPHAGES IN PATIENTS WITH SCLERODERMA

1989 • 50 citations

Serum Levels of Aminoterminal Type III Procollagen Peptide and Hyaluronan Predict Mortality in Systemic Sclerosis

1992 • 39 citations

Soluble immunologic products in scleroderma sera

1991 • 37 citations

Visceral Improvement Following Combined Plasmapheresis and Immunosuppressive Drug Therapy in Progressive Systemic Sclerosis

1988 • 35 citations

Esophageal Dysfunction and Radionuclide Transit in Progressive Systemic Sclerosis

1987 • 34 citations

Pulmonary Mechanics in Normal Men, Studied with the Flow Regulator Method

1970 • 24 citations

Lung function in progressive systemic sclerosis is dominated by poorly compliant lungs and stiff airways.

1985 • 17 citations

Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.

1991 • 12 citations